Plain-English translation of NCT06109454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether Huaier Granules, a natural supplement, can work as well as standard chemotherapy in preventing lung cancer from coming back after surgery. The study will follow 240 patients with stage II-IIIA non-small cell lung cancer who have already had surgery to remove their tumor. Half will take the medication daily, while the other half will receive traditional chemotherapy, and researchers will track how many people remain cancer-free over three years.
After lung cancer surgery, doctors typically give chemotherapy to reduce the risk of cancer returning. However, some patients cannot tolerate chemotherapy or prefer not to receive it. This trial explores whether this natural supplement might offer a gentler alternative with similar results.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be placed in one of two groups: one group will take Huaier Granules by mouth as their follow-up treatment, while the other group will receive standard platinum-based chemotherapy. The study will track your health and any side effects for three years, monitoring whether your cancer stays away. You will need to visit the research center for regular check-ups and provide information about your health status during this time.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
China
Sponsor
Liaoning Cancer Hospital & Institute
Collaborators
LinkDoc Technology (Beijing) Co. Ltd., Huazhong University of Science and Technology
Enrollment target
~240 participants
Started
March 2024
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hongxu Liu, PhD
Liaoning Cancer Hospital & Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.